Scientists hunt for genetic clues in families prone to blood cancers
NCT ID NCT00039676
First seen Nov 01, 2025 · Last updated Jun 22, 2026 · Updated 32 times
Summary
This study looks at people and families who have a higher chance of developing blood or lymph node cancers, like leukemia or lymphoma. Researchers want to understand what causes this higher risk, including genetic and environmental factors. Participants provide medical history, blood or cheek cell samples, and may have additional tests at the NIH. The goal is to find clues that could lead to better prevention and early detection.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC LYMPHOCYTIC LEUKEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
NIH National Cancer Institute - Shady Grove
Rockville, Maryland, 20850, United States
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could identify genes and risk factors that lead to better screening and prevention strategies for blood cancers in high-risk families.
What could go wrong
This is an observational study, not a treatment trial. It may not directly benefit participants, and findings may take years to translate into clinical practice.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.